Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Regulatory Trackers
R&D
Agency Leadership
Compliance
Complete Response Letters
Drug Review Profiles
Scrip
Why India Is Considering The Essential Commodities Act For Pharma Amid Iran War
US And Europe Could Face Higher Prices
Apr 01 2026
•
By
Vibha Ravi
Indian Pharma Is Suffering Repercussions Of The US-Israel Coalition's Attack On Iran
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Legislation
More from Pink Sheet